JOHN H BAUER
CIK 1248055 · last filed 2015-09-25
JOHN H BAUER is a corporate insider who has filed 28 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for CTIC, was dated Sep 25, 2015. Across all open-market trades the lifetime net is −$164.0K, making them a net seller over the disclosed history. 6 SEC filings were submitted jointly with ZONES INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
28
-$164.0K
Filer Profile
SEATTLE, WA 98102
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTI BIOPHARMA CORP (CTIC) Delisted | Director | — | $9.09 | — | $0 | 1 | 2015-09-25 |
| CTI BIOPHARMA CORP (TRGT) Delisted | Director | 80,595 | — | — | -$164.0K | 25 | 2014-01-31 |
| ZONES INC (ZONS) Delisted | Director | 36,300 | — | — | $0 | 2 | 2008-12-31 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-09-25 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-31 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | +146,000 | $0 | EDGAR |
| 2013-12-12 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-06-28 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | +86,957 | $0 | EDGAR |
| 2013-03-22 | CTI BIOPHARMA CORP (TRGT) Delisted | Mixed | +81,798 | $0 | EDGAR |
| 2012-12-05 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | +71,429 | $0 | EDGAR |
| 2012-06-28 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | +27,415 | $0 | EDGAR |
| 2012-01-04 | CTI BIOPHARMA CORP (TRGT) Delisted | Mixed | +350,251 | $0 | EDGAR |
| 2011-12-01 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | +187,292 | $0 | EDGAR |
| 2011-11-15 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | +3,333 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.